Darren S Cline Insider Trading $GWPH GW PHARMACEUTICALS PLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Darren S Cline.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Darren S Cline. Darren S Cline is EVP, Commercial in SEATTLE GENETICS INC /WA ($SGEN) and Executive Vice President in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and SVP, Commercial in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and U.S. Chief Commercial Officer in GW PHARMACEUTICALS PLC ($GWPH).
Darren S Cline in GW PHARMACEUTICALS PLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Darren S Cline: U.S. Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: May 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Darren S Cline in GW PHARMACEUTICALS PLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GWPH, SGEN, STML
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 75,024 | 128 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 46,896 | 80 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 177,180 | 301 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 106,320 | 181 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 98,040 | 167 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 22,068 | 38 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 15.30 | 54,192 | 829,230 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Sell | D | 0.00 | 5,556 | 0 | 0 | 5.6 K to 0 (-100.00 %) |
| Mar 04 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | A | 0.00 | 46,896 | 66 | 46,896 | |
| Mar 04 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | A | 0.00 | 75,024 | 105 | 75,024 | |
| Feb 24 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | A | 0.00 | 75,024 | 105 | 75,024 | |
| Feb 24 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | A | 0.00 | 46,896 | 66 | 46,896 | |
| Jun 08 2020 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | A | 0.00 | 106,320 | 138 | 106,320 | |
| Jun 08 2020 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | A | 0.00 | 177,180 | 230 | 177,180 | |
| May 29 2020 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | M | 0.00 | 7,356 | 9 | 0 | |
| May 29 2020 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Payment of Exercise | F | 10.54 | 1,800 | 18,972 | 5,556 | 3.8 K to 5.6 K (+47.92 %) |
| May 29 2020 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Buy | M | 0.00 | 7,356 | 9 | 7,356 | 0 to 7.4 K |
| May 30 2019 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | A | 0.00 | 98,040 | 127 | 98,040 | |
| May 30 2019 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | A | 15.30 | 54,192 | 829,138 | 54,192 | |
| May 30 2019 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Grant | A | 0.00 | 29,424 | 38 | 29,424 | 0 to 29.4 K |
Page: 1